E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The US FDA approval follows Lupin’s recent launch of Formoflo-G metered-dose inhaler for chronic obstructive pulmonary disease (COPD) in India
imphoenix82
Regeneron to receive USD 1 billion upfront payment from Sanofi, with potential for up to an additional USD 7 billion in future milestone payments.
imphoenix82
Apitoria Pharma, a 100% subsidiary of Aurobindo Pharma, has incorporated a new wholly owned subsidiary by the name of ‘Avogent Lifesciences’ in India.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
